2nd Quarter - Report

AMERICAN CLINICAL LABORATORY ASSN for AMERICAN CLINICAL LABORATORY ASSN

Firm
Client
Income
—
Expenses
$260,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Implementation of the Medicare Modernizaton Act of 2003 statutory provisions, actions governing coding, coverage, and payment for laboratory tests, implementation of electronic health records, oversight of genetic testing, POD or condo laboratories, legislation governing reimbursement for Medicare's Physician Fee Schedule; health reform; HR 1699/S 1220; HR 1452

LobbyistCovered position, as disclosed
JASON DUBOIS Vice President, Government Relations
JO ANNE GLISSON Senior Vice President
ALAN MERTZ President
DAVID ALAN MONGILLO Vice President, Policy and Medical Affairs

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE; Centers For Disease Control & Prevention (CDC)

Bills named: H.R. 1699 (111th), H.R. 1452 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.